Allena Ji

1.0k total citations
22 papers, 623 citations indexed

About

Allena Ji is a scholar working on Molecular Biology, Physiology and Pharmacology. According to data from OpenAlex, Allena Ji has authored 22 papers receiving a total of 623 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 7 papers in Physiology and 5 papers in Pharmacology. Recurrent topics in Allena Ji's work include Lysosomal Storage Disorders Research (6 papers), Antibiotics Pharmacokinetics and Efficacy (5 papers) and Carbohydrate Chemistry and Synthesis (3 papers). Allena Ji is often cited by papers focused on Lysosomal Storage Disorders Research (6 papers), Antibiotics Pharmacokinetics and Efficacy (5 papers) and Carbohydrate Chemistry and Synthesis (3 papers). Allena Ji collaborates with scholars based in United States, France and Germany. Allena Ji's co-authors include D.W. Jacobsen, Susan R. Savon, Michel Peterschmitt, George A. Díaz, Robin Lachmann, Melissa Wasserstein, Mauricio Leal, Nigel P.S. Crawford, Jennifer Davis and Sebastiaan J.M. Gaemers and has published in prestigious journals such as Neurology, Journal of Pharmacology and Experimental Therapeutics and Clinical Chemistry.

In The Last Decade

Allena Ji

22 papers receiving 607 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Allena Ji United States 13 211 210 78 77 71 22 623
Ayako Furugen Japan 17 327 1.5× 86 0.4× 75 1.0× 98 1.3× 46 0.6× 90 931
Peihua Lu Canada 14 418 2.0× 195 0.9× 73 0.9× 38 0.5× 18 0.3× 21 1.0k
Joo‐Yeun Oh United States 16 417 2.0× 202 1.0× 34 0.4× 98 1.3× 43 0.6× 34 805
Matthias Schittmayer Austria 18 428 2.0× 127 0.6× 37 0.5× 154 2.0× 52 0.7× 42 844
Silvia Funghini Italy 17 231 1.1× 66 0.3× 107 1.4× 38 0.5× 22 0.3× 36 567
Rajeshwary Ghosh United States 13 410 1.9× 73 0.3× 96 1.2× 46 0.6× 42 0.6× 29 836
Shihai Yan China 14 299 1.4× 66 0.3× 68 0.9× 54 0.7× 94 1.3× 42 617
Alessio Lepore Italy 9 315 1.5× 100 0.5× 23 0.3× 26 0.3× 18 0.3× 14 695
В. И. Сергиенко Russia 12 149 0.7× 166 0.8× 39 0.5× 31 0.4× 33 0.5× 78 606

Countries citing papers authored by Allena Ji

Since Specialization
Citations

This map shows the geographic impact of Allena Ji's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Allena Ji with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Allena Ji more than expected).

Fields of papers citing papers by Allena Ji

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Allena Ji. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Allena Ji. The network helps show where Allena Ji may publish in the future.

Co-authorship network of co-authors of Allena Ji

This figure shows the co-authorship network connecting the top 25 collaborators of Allena Ji. A scholar is included among the top collaborators of Allena Ji based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Allena Ji. Allena Ji is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Peterschmitt, Michel, et al.. (2023). Plasma glucosylsphingosine correlations with baseline disease burden and response to eliglustat in two clinical trials of previously untreated adults with Gaucher disease type 1. Molecular Genetics and Metabolism. 138(3). 107527–107527. 4 indexed citations
2.
3.
Peterschmitt, Michel, et al.. (2020). Pharmacokinetics, Pharmacodynamics, Safety, and Tolerability of Oral Venglustat in Healthy Volunteers. Clinical Pharmacology in Drug Development. 10(1). 86–98. 69 indexed citations
4.
Schiffmann, Raphael, Timothy M. Cox, Hiroyuki Ida, et al.. (2020). Venglustat combined with imiglucerase positively affects neurological features and brain connectivity in adults with Gaucher disease type 3. Molecular Genetics and Metabolism. 129(2). S144–S145. 4 indexed citations
5.
6.
Fischer, Tanya, Thomas Gasser, Stuart Isaacson, et al.. (2019). Safety, tolerability and pharmacokinetics of oral venglustat in Parkinson’s disease patients with a GBA mutation (S4.002). Neurology. 92(15_supplement). 3 indexed citations
7.
Peterschmitt, Michel, Thomas Gasser, Stuart Isaacson, et al.. (2019). Safety, tolerability and pharmacokinetics of oral venglustat in Parkinson disease patients with a GBA mutation. Molecular Genetics and Metabolism. 126(2). S117–S117. 15 indexed citations
8.
Peterschmitt, Michel, Meredith C. Foster, Kate Zhang, Allena Ji, & Gerald F. Cox. (2019). Correlations between glucosylsphingosine (lyso-GL-1) and baseline disease severity as well as response to treatment in two clinical trials of eliglustat in treatment-naïve adults with type 1 Gaucher disease. Molecular Genetics and Metabolism. 126(2). S117–S117. 3 indexed citations
9.
Wasserstein, Melissa, George A. Díaz, Robin Lachmann, et al.. (2018). Olipudase alfa for treatment of acid sphingomyelinase deficiency (ASMD): safety and efficacy in adults treated for 30 months. Journal of Inherited Metabolic Disease. 41(5). 829–838. 80 indexed citations
10.
Ji, Allena, et al.. (2016). Enhancement of human plasma glucosylceramide assay sensitivity using delipidized plasma. Molecular Genetics and Metabolism Reports. 8. 77–79. 5 indexed citations
11.
Ji, Allena, et al.. (2015). A Novel Approach for Quantitation of Glucosylceramide in Human Dried Blood Spot Using LC–MS/MS. Bioanalysis. 7(12). 1483–1496. 10 indexed citations
12.
Bhattacharya, Indranil, et al.. (2013). Reassessment of tigecycline bone concentrations in volunteers undergoing elective orthopedic procedures. The Journal of Clinical Pharmacology. 54(1). 70–74. 13 indexed citations
13.
Ji, Allena, et al.. (2013). Ultrasensitive and Automated 1 Pg/Ml Fluticasone Propionate Assay in Human Plasma Using LC–MS/MS. Bioanalysis. 5(4). 423–435. 3 indexed citations
14.
Ji, Allena, et al.. (2009). Determination of Tigecycline in Human Skin Using a Novel Validated LC–MS/MS Method. Bioanalysis. 2(1). 81–94. 16 indexed citations
15.
Ji, Allena, et al.. (2008). A sensitive human bone assay for quantitation of tigecycline using LC/MS/MS. Journal of Pharmaceutical and Biomedical Analysis. 48(3). 866–875. 38 indexed citations
16.
Ji, Allena, et al.. (2007). A novel antibiotic bone assay by liquid chromatography/tandem mass spectrometry for quantitation of tigecycline in rat bone. Journal of Pharmaceutical and Biomedical Analysis. 44(4). 970–979. 25 indexed citations
17.
Hennan, James K., Hassan Elokdah, Mauricio Leal, et al.. (2005). Evaluation of PAI-039 [{1-Benzyl-5-[4-(trifluoromethoxy)phenyl]-1 H-indol-3-yl}(oxo)acetic Acid], a Novel Plasminogen Activator Inhibitor-1 Inhibitor, in a Canine Model of Coronary Artery Thrombosis. Journal of Pharmacology and Experimental Therapeutics. 314(2). 710–716. 35 indexed citations
18.
19.
Ji, Allena, et al.. (1995). Separation of urinary estrogens by micellar electrokinetic chromatography. Journal of Chromatography B Biomedical Sciences and Applications. 669(1). 15–26. 49 indexed citations
20.
Ji, Allena, Susan R. Savon, & D.W. Jacobsen. (1995). Determination of total serum sulfite by HPLC with fluorescence detection. Clinical Chemistry. 41(6). 897–903. 122 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ayako Furugen Breakdown of academic impact, for papers by Peihua Lu Breakdown of academic impact, for papers by Joo‐Yeun Oh Breakdown of academic impact, for papers by Matthias Schittmayer Breakdown of academic impact, for papers by Silvia Funghini Breakdown of academic impact, for papers by Rajeshwary Ghosh Breakdown of academic impact, for papers by Shihai Yan Breakdown of academic impact, for papers by Alessio Lepore Breakdown of academic impact, for papers by В. И. Сергиенко
Rankless by CCL
2026